Healthcare provider profile · identity verified

Sachin Jain, MD

Allopathic & Osteopathic Physicians|Internal Medicine · WAUKEGAN, IL · NPI 1326292228

Profile state: payments and partd Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

CMS Open Payments records show Sachin Jain, MD received $107.30 in general payments during 2025 across 4 reported records.

ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) accounted for 78.0% of that reported general-payment amount.

The Open Payments records used for this analysis explicitly named 2 associated products.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

$107.30

4 reported records · 2 companies

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Who paid this doctor?

Companies in 2025 General Payments

Reported company	Canonical company	Amount	Share	Records	Year
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)	Unresolved — no canonical attribution shown	$83.67	78.0%	3	2025
Abbott Laboratories	Unresolved — no canonical attribution shown	$23.63	22.0%	1	2025

What were the payments for?

Payment categories

Category	Amount	Records
Food and Beverage	$107.30	4

A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.

Analysis 1 · Payment-linked products

Products named in Open Payments records

Reported product	Type	Reported company	Related amount*	Records	Year
CAPLYTA Normalized: caplyta	Drug	ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)	$83.67	3	2025
Source payment records 2025-06-25 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $24.01 · Open Payments source 2025-07-23 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $30.14 · Open Payments source 2025-08-29 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $29.52 · Open Payments source
FREESTYLE LIBRE 3 Normalized: freestyle libre 3	Device	Abbott Laboratories	$23.63	1	2025
Source payment records 2025-11-11 · Abbott Laboratories · $23.63 · Open Payments source

* Product-associated amounts are non-additive because one payment record may name more than one product.

These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.

Public prescribing for products named in payments

No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	1598	259
Eliquis	Apixaban	865	84
Gabapentin	Gabapentin	807	127
Tamsulosin Hcl	Tamsulosin Hcl	702	97
Levothyroxine Sodium	Levothyroxine Sodium	672	98
Amlodipine Besylate	Amlodipine Besylate	660	158
Metformin Hcl	Metformin Hcl	584	110
Furosemide	Furosemide	557	112
Pantoprazole Sodium	Pantoprazole Sodium	536	98
Lisinopril	Lisinopril	447	75
Potassium Chloride	Potassium Chloride	440	89
Omeprazole	Omeprazole	417	75
Metoprolol Tartrate	Metoprolol Tartrate	413	92
Quetiapine Fumarate	Quetiapine Fumarate	409	62
Losartan Potassium	Losartan Potassium	379	76
Trazodone Hcl	Trazodone Hcl	310	57
Carvedilol	Carvedilol	309	73
Clopidogrel	Clopidogrel Bisulfate	298	48
Divalproex Sodium	Divalproex Sodium	273	46
Levetiracetam	Levetiracetam	272	38
Metoprolol Succinate	Metoprolol Succinate	247	51
Mirtazapine	Mirtazapine	239	47
Hydralazine Hcl	Hydralazine Hcl	205	46
Escitalopram Oxalate	Escitalopram Oxalate	203	36
Simvastatin	Simvastatin	202	45
Warfarin Sodium	Warfarin Sodium	201	18
Donepezil Hcl	Donepezil Hcl	192	30
Sertraline Hcl	Sertraline Hcl	174	31
Duloxetine Hcl	Duloxetine Hcl	170	32
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	163	54
Allopurinol	Allopurinol	161	30
Albuterol Sulfate Hfa	Albuterol Sulfate	157	73
Alendronate Sodium	Alendronate Sodium	157	19
Risperidone	Risperidone	156	21
Bumetanide	Bumetanide	155	34
Famotidine	Famotidine	153	28
Fluticasone Propionate	Fluticasone Propionate	150	47
Jardiance	Empagliflozin	148	25
Midodrine Hcl	Midodrine Hcl	146	48
Spironolactone	Spironolactone	135	29
Benztropine Mesylate	Benztropine Mesylate	132	25
Carbidopa-Levodopa	Carbidopa/Levodopa	132	21
Finasteride	Finasteride	128	17
Entresto	Sacubitril/Valsartan	125	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	123	35
Montelukast Sodium	Montelukast Sodium	108	24
Buspirone Hcl	Buspirone Hcl	106	20
Memantine Hcl	Memantine Hcl	104	19
Pravastatin Sodium	Pravastatin Sodium	104	19
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	100	16
Trulicity	Dulaglutide	97	17
Prednisone	Prednisone	95	31
Sevelamer Carbonate	Sevelamer Carbonate	95	12
Oxybutynin Chloride Er	Oxybutynin Chloride	93	15
Divalproex Sodium Er	Divalproex Sodium	92	11
Carbamazepine	Carbamazepine	88	suppressed
Olanzapine	Olanzapine	88	23
Baclofen	Baclofen	87	18
Tradjenta	Linagliptin	87	suppressed
Xarelto	Rivaroxaban	86	14
Januvia	Sitagliptin Phosphate	84	suppressed
Naproxen	Naproxen	83	31
Lactulose	Lactulose	82	15
Fluoxetine Hcl	Fluoxetine Hcl	81	11
Meloxicam	Meloxicam	78	19
Insulin Lispro	Insulin Lispro	76	28
Hydroxyzine Hcl	Hydroxyzine Hcl	75	32
Ondansetron Hcl	Ondansetron Hcl	75	49
Gentamicin Sulfate	Gentamicin Sulfate	73	16
Glipizide	Glipizide	73	20
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	73	37
Fenofibrate	Fenofibrate Nanocrystallized	71	13
Haloperidol Decanoate	Haloperidol Decanoate	67	11
Tizanidine Hcl	Tizanidine Hcl	67	19
Nifedipine Er	Nifedipine	66	11
Ozempic	Semaglutide	66	12
Rivastigmine	Rivastigmine Tartrate	66	suppressed
Ezetimibe	Ezetimibe	65	11
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	64	49
Digoxin	Digoxin	64	12
Latanoprost	Latanoprost	63	15
Amiodarone Hcl	Amiodarone Hcl	62	17
Rosuvastatin Calcium	Rosuvastatin Calcium	62	15
Propranolol Hcl	Propranolol Hcl	61	12
Enoxaparin Sodium	Enoxaparin Sodium	59	suppressed
Sucralfate	Sucralfate	59	11
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	56	20
Myrbetriq	Mirabegron	55	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	54	13
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	54	29
Lantus	Insulin Glargine,hum.Rec.Anlog	53	19
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	52	11
Lamotrigine	Lamotrigine	51	suppressed
Vascepa	Icosapent Ethyl	51	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	50	suppressed
Aripiprazole	Aripiprazole	50	suppressed
Cephalexin	Cephalexin	50	29
Paroxetine Hcl	Paroxetine Hcl	50	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	49	17
Invega Sustenna	Paliperidone Palmitate	48	suppressed
Budesonide	Budesonide	47	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	47	36
Phenytoin Sodium Extended	Phenytoin Sodium Extended	47	suppressed
Fenofibrate	Fenofibrate,micronized	46	suppressed
Haloperidol	Haloperidol	45	14
Sodium Chloride	0.9 % Sodium Chloride	42	24
Atropine Sulfate	Atropine Sulfate	41	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	41	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	40	11
Ciprofloxacin Hcl	Ciprofloxacin Hcl	40	35
Megestrol Acetate	Megestrol Acetate	40	suppressed
Trihexyphenidyl Hcl	Trihexyphenidyl Hcl	40	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	40	suppressed
Amoxicillin	Amoxicillin	39	22
Incruse Ellipta	Umeclidinium Bromide	39	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	39	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	39	suppressed
Clomipramine Hcl	Clomipramine Hcl	38	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	38	suppressed
Scopolamine	Scopolamine	38	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	37	suppressed
Ropinirole Hcl	Ropinirole Hcl	37	suppressed
Glimepiride	Glimepiride	36	11
Glipizide Er	Glipizide	36	suppressed
Diltiazem Hcl	Diltiazem Hcl	35	suppressed
Meropenem	Meropenem	35	11
Triamcinolone Acetonide	Triamcinolone Acetonide	35	18
Ipratropium Bromide	Ipratropium Bromide	34	suppressed
Atenolol	Atenolol	33	suppressed
Dulera	Mometasone/Formoterol	33	11
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	33	suppressed
Linzess	Linaclotide	33	suppressed
Oxcarbazepine	Oxcarbazepine	33	suppressed
Fenofibrate	Fenofibrate	32	suppressed
Breo Ellipta	Fluticasone/Vilanterol	31	suppressed
Clozapine	Clozapine	31	suppressed
Methylprednisolone	Methylprednisolone	31	17
Tresiba Flextouch U-100	Insulin Degludec	31	suppressed
Methenamine Hippurate	Methenamine Hippurate	30	suppressed
Terazosin Hcl	Terazosin Hcl	30	suppressed
Tramadol Hcl	Tramadol Hcl	30	14
Calcium Acetate	Calcium Acetate	29	suppressed
Glycopyrrolate	Glycopyrrolate	29	suppressed
Ibuprofen	Ibuprofen	29	14
Fluphenazine Hcl	Fluphenazine Hcl	28	suppressed
Glucagon Emergency Kit	Glucagon	28	19
Levofloxacin	Levofloxacin	28	22
Metformin Hcl Er	Metformin Hcl	28	suppressed
Primidone	Primidone	28	suppressed
Amantadine	Amantadine Hcl	27	suppressed
Chlorpromazine Hcl	Chlorpromazine Hcl	27	suppressed
Enalapril Maleate	Enalapril Maleate	26	suppressed
Methimazole	Methimazole	26	suppressed
Ranolazine Er	Ranolazine	26	suppressed
Albuterol Sulfate	Albuterol Sulfate	25	12
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	25	11
Rexulti	Brexpiprazole	25	suppressed
Valproic Acid	Valproic Acid	25	suppressed
Valproic Acid	Valproic Acid (As Sodium Salt)	25	suppressed
Ventolin Hfa	Albuterol Sulfate	25	13
Verapamil Hcl	Verapamil Hcl	25	suppressed
Hydrocortisone	Hydrocortisone	24	suppressed
Labetalol Hcl	Labetalol Hcl	24	suppressed
Meclizine Hcl	Meclizine Hcl	24	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	24	19
Topiramate	Topiramate	24	suppressed
Invokana	Canagliflozin	23	suppressed
Nuplazid	Pimavanserin Tartrate	23	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	22	suppressed
Azelastine Hcl	Azelastine Hcl	22	suppressed
Azithromycin	Azithromycin	22	21
Konvomep	Omeprazole/Sodium Bicarbonate	22	suppressed
Cefepime Hcl	Cefepime Hcl	21	suppressed
Dabigatran Etexilate	Dabigatran Etexilate Mesylate	21	suppressed
Novolog	Insulin Aspart	21	suppressed
Valsartan	Valsartan	21	suppressed
Clotrimazole	Clotrimazole	20	11
Metoclopramide Hcl	Metoclopramide Hcl	20	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	20	suppressed
Rybelsus	Semaglutide	20	suppressed
Savella	Milnacipran Hcl	20	suppressed
Sodium Polystyrene Sulfonate	Sodium Polystyrene Sulfonate	20	13
Timolol Maleate	Timolol Maleate	20	suppressed
Vancomycin Hcl	Vancomycin Hcl	20	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	19	suppressed
Enulose	Lactulose	19	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	19	suppressed
Ketoconazole	Ketoconazole	18	suppressed
Lithium Carbonate	Lithium Carbonate	18	suppressed
Lovastatin	Lovastatin	18	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	18	15
Nebivolol Hcl	Nebivolol Hcl	18	suppressed
Phenytek	Phenytoin Sodium Extended	18	suppressed
Bicalutamide	Bicalutamide	17	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	17	suppressed
Metolazone	Metolazone	17	suppressed
Nyamyc	Nystatin	17	suppressed
Nystatin	Nystatin	17	15
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	16	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	16	suppressed
Calcitriol	Calcitriol	16	suppressed
Celecoxib	Celecoxib	16	suppressed
Citalopram Hbr	Citalopram Hydrobromide	16	suppressed
Diltiazem 24hr Er (Xr)	Diltiazem Hcl	16	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	16	suppressed
Insulin Aspart Flexpen	Insulin Aspart	16	suppressed
Nitroglycerin	Nitroglycerin	16	suppressed
Sps	Sodium Polystyrene Sulfon/Sorb	16	15
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	15	suppressed
Cefpodoxime Proxetil	Cefpodoxime Proxetil	15	13
Diclofenac Sodium	Diclofenac Sodium	15	suppressed
Entacapone	Entacapone	15	suppressed
Farxiga	Dapagliflozin Propanediol	15	suppressed
Alprazolam	Alprazolam	14	suppressed
Carbidopa-Levodopa Er	Carbidopa/Levodopa	14	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	14	suppressed
Fluphenazine Decanoate	Fluphenazine Decanoate	14	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	14	suppressed
Meropenem-0.9% Nacl	Meropenem-0.9% Sodium Chloride	14	suppressed
Mometasone Furoate	Mometasone Furoate	14	suppressed
Biktarvy	Bictegrav/Emtricit/Tenofov Ala	13	suppressed
Colchicine	Colchicine	13	suppressed
Creon	Lipase/Protease/Amylase	13	suppressed
Fesoterodine Fumarate Er	Fesoterodine Fumarate	13	suppressed
Humalog	Insulin Lispro	13	suppressed
Misoprostol	Misoprostol	13	suppressed
Symbicort	Budesonide/Formoterol Fumarate	13	suppressed
Bethanechol Chloride	Bethanechol Chloride	12	suppressed
Ceftriaxone	Ceftriaxone Sodium	12	suppressed
Dapagliflozin	Dapagliflozin Propanediol	12	suppressed
Desmopressin Acetate	Desmopressin Acetate	12	suppressed
Dropsafe Pen Needle	Pen Needle, Diabetic, Safety	12	suppressed
Fiasp Flextouch	Insulin Aspart (Niacinamide)	12	suppressed
Haloperidol Lactate	Haloperidol Lactate	12	suppressed
Klor-Con M20	Potassium Chloride	12	suppressed
Memantine Hcl Er	Memantine Hcl	12	suppressed
Nabumetone	Nabumetone	12	suppressed
Nystop	Nystatin	12	suppressed
Tigecycline	Tigecycline	12	suppressed
Tolterodine Tartrate	Tolterodine Tartrate	12	suppressed
Torsemide	Torsemide	12	suppressed
Vancomycin Hcl	Vancomycin/Water For Inj (Peg)	12	suppressed
Veltassa	Patiromer Calcium Sorbitex	12	suppressed
Cholestyramine	Cholestyramine (With Sugar)	11	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	11	suppressed
Gemtesa	Vibegron	11	suppressed
Lokelma	Sodium Zirconium Cyclosilicate	11	suppressed
Mesalamine	Mesalamine	11	suppressed
Minoxidil	Minoxidil	11	suppressed
Permethrin	Permethrin	11	11
Rasagiline Mesylate	Rasagiline Mesylate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	$107.30 · 4 records	ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)	CAPLYTA, FREESTYLE LIBRE 3	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error